台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    59.3
  • 漲跌
    ▼0.5
  • 漲幅
    -0.84%
  • 成交量
    24
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-群益金鼎-開元 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-開元 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/2700.00161.0061.00-1138-0.72%
2024/12/26161.8000.0061.8011390.72%
2024/11/29164.50163.9063.9001430.00%
2024/11/2600.00164.5064.50-1145-0.69%
2024/11/2000.00264.0063.80-2148-1.34%
2024/11/19465.93164.0063.8031462.05%
2024/09/2400.00457.8857.90-4140-2.84%
2024/09/23356.60157.1056.5021421.41%
2024/09/20257.1000.0057.1021451.37%
2024/09/1900.00157.0057.50-1151-0.66%
2024/09/18356.03356.8756.3001570.00%
2024/09/16155.50255.8555.60-1157-0.63%
2024/09/1300.00155.4055.50-1159-0.63%
2024/09/1200.00156.0055.40-1161-0.62%
2024/09/11355.63555.3454.80-2162-1.23%
2024/09/10455.55256.5055.6021621.23%
2024/09/09256.80156.6056.8011620.62%
2024/09/0600.00157.4057.00-1163-0.61%
2024/09/05456.88258.0056.7021651.21%
2024/09/04257.40258.1557.4001670.00%
2024/09/03258.6000.0058.6021691.18%
2024/08/3000.00459.7859.80-4174-2.30%
2024/08/29258.6000.0059.2021741.15%
2024/08/28258.9500.0059.3021761.13%
2024/08/1900.00157.8057.90-1186-0.54%
2024/08/16157.80158.5057.8001870.00%
2024/08/1500.00257.4558.20-2191-1.05%
2024/08/14356.20156.9056.2021931.03%
2024/08/1300.00157.0056.50-1198-0.50%
2024/08/1200.00256.7056.60-2201-0.99%
2024/08/09456.23256.8056.2022030.98%
2024/08/081056.49856.7156.2022010.99%
2024/07/30368.10366.4066.2002310.00%
2024/07/10261.00461.4561.40-2233-0.86%
2024/07/09261.50362.9061.50-1232-0.43%
2024/07/08263.95163.6063.5012290.44%
2024/07/0500.00168.4067.50-1222-0.45%
2024/07/04267.10268.6067.8002230.00%
2024/07/03368.9000.0068.9032251.33%
2024/07/0200.00469.5069.20-4226-1.77%
2024/07/01468.6500.0068.5042261.77%
2024/06/2800.00269.8569.70-2229-0.87%
2024/06/27269.00469.9068.80-2231-0.86%
2024/06/26469.6500.0069.8042301.74%
2024/06/2400.00166.8068.50-1225-0.44%
2024/06/20164.90465.4364.70-3222-1.35%
2024/06/19363.57164.3063.4022210.90%
2024/06/18164.00364.2764.40-2220-0.91%
2024/06/17463.23263.0063.4022190.91%
2024/06/14263.60364.3363.50-1219-0.46%
2024/06/13364.00364.5764.0002190.00%
2024/06/12564.60365.2764.2022200.91%
2024/06/11166.70368.2066.70-2217-0.92%
2024/06/07366.1000.0066.3032171.38%
2024/05/0900.00167.0067.10-1313-0.32%
2024/05/0800.00164.5064.40-1299-0.33%
2024/05/02259.60258.2060.5002680.00%
2024/03/0500.00161.1061.20-1228-0.44%
2024/02/2700.00161.1064.30-1216-0.46%
2024/02/23163.40260.1561.00-1202-0.49%
2024/02/22560.10260.4060.0031931.55%
東生華加速16項新品專案開發 目標未來5年營收翻倍Anue鉅亨-2024/12/20
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華 相關文章